After uzbekistan on wednesday connected the deaths of 18 children to an indian cough medication, sources said the Union government has requested a causality status. Months after a similar occurrence was recorded in Gambia, the Uzbek health ministry has claimed that 18 children have died in the nation while taking medications made by an indian pharmaceutical business. In uzbekistan, Marion Biotech, the company in question, was established in 2012.

The Dok-1 Max Syrup, made by Noida-based Marion Biotech, was what the children who died had taken, according to a statement from the Uzbek health ministry. The government reported that so far, ingesting Doc-1 Max syrup has caused the deaths of 18 out of 21 youngsters who had acute respiratory illnesses. "It was discovered that the deceased youngsters took this drug at home for two to seven days, three to four times per day, 2.5 to five millilitres, which exceeds the normal dose of the drug for children," the statement said.

It was further stated that preliminary laboratory tests had revealed the presence of ethylene glycol, the toxic substance blamed for fatalities in the Gambia, in the Dok-1 Max syrup. According to authorities inside the Central drugs Standard Control Organization (CDSCO), this specific syrup is not currently being offered for sale in the indian market.

Find out more: